Skip to content

Mescaline research published in 2022

Page 2 of 2: studies 21 to 27 of 27, newest first. Back to the mescaline overview

Studies

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Journal of Psychopharmacology March 1, 2022 Malin Vedøy Uthaug, Alan K. Davis, Trevor Forrest Haas et al. 64 citations

Mescaline is a naturally occurring psychoactive phenethylamine found in several cacti and historically used ceremonially by Indigenous and Latin American populations. Broader recognition of its possible therapeutic value in Western science began in the 1950s; however, knowledge of the safety profile of mescaline and the extent of its use remains limited. The primary aim of this study is to...

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines

Frontiers in Pharmacology February 9, 2022 Karolina E. Kolaczynska, Dino Luethi, Dino Luethi et al. 16 citations

3,4,5-Trimethoxyphenethylamine (mescaline) is a psychedelic alkaloid found in peyote cactus. Related 4-alkoxy-3,5-dimethoxy-substituted phenethylamines (scalines) and amphetamines (3C-scalines) are reported to induce similarly potent psychedelic effects and are therefore potential novel therapeutics for psychedelic-assisted therapy. Herein, several pharmacologically uninvestigated scalines and...

Psychedelics hold promise for primary care research

Family Practice January 24, 2022 James Bailey Sanford

Dear Editor, We are in the midst of a so-called “psychedelic renaissance,” a time of renewed interest in the therapeutic potential of psychoactive drugs such as psilocybin, mescaline, and lysergic acid diethylamide. When they first emerged as topics of academic interest in the mid-20th century, these substances were greeted with exuberance for their apparent panacea-like effects in treating a...

Behavioral and neurochemical effects of novel N-Benzyl-2-phenylethylamine derivatives in adult zebrafish

bioRxiv (Cold Spring Harbor Laboratory) January 21, 2022 Konstantin A. Demin, Olga V. Kupriyanova, Вадим А. Шевырин et al. preprint

Abstract Serotonergic hallucinogenic drugs potently affect human brain and behavior, and have recently emerged as potentially promising agents in psychopharmacotherapy. Complementing rodent studies, zebrafish ( Danio rerio ) is a powerful animal model for screening neuroactive drugs, including serotonergic agents. Here, we test ten different N-Benzyl-2-phenylethylamine (NBPEA) derivatives with...

EXPERT RESEARCH OF SUBSTANCES OF GROUP OF DERIVATIVES OF PHENYLETHYLAMINE (ON EXAMPLE OF MESCALINE AND 2С-В)

Criminalistics and Forensics 2022 Dmytro Shynkarenko, Inna Konopatska, Roman Tsynda et al.

General physical and chemical descriptions of phenylethylamine presented grosses-formulas, the molecular masses and indexes of chromatography maintenance of derivatives of phenylethylamine, register in the article, mescaline, and 2С-В behave to that. During expert research of substances of a group of derivatives of phenylethylamine, the task of quality authentication of research objects that...

Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation

Current Topics in Behavioral Neurosciences 2022 Matthew W. Johnson 31 citations

This manuscript reviews research suggesting that classic psychedelics (5-HT2A receptor agonists) are effective in treating addictions including tobacco use disorder. I review historical research from the 1950s to 1970s suggesting that classic psychedelics are associated with addiction recovery across pharmacologically distinct drugs of addiction. I then review anthropological reports about...

Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension

Journal of Psychopharmacology 2022 Grant Jones, Matthew K. Nock 30 citations

Background: The United States boasts the largest prison population in the world, conferring significant direct and indirect costs (e.g. lost wages for the incarcerated, increased morbidity/mortality, etc.) to society. Recidivism rates are high for the imprisoned and most interventions to reduce criminality are minimally effective. Thus, in addition to the need for criminal justice reform, there...